20107 results

Naila Badalova

Shahd Algorashi

Riyadh, Saudi Arabia

Kyriakos Panaou

Groningen, Netherlands

Feyza Mollaalioglu

Vijayan Ganesan

KANNUR, India

Jaroslav Januska

Trinec, Czech Republic

Lania Yara

Stockholm, Sweden

Rozanne Johnston

Melbourne, Australia

Paul Thomas

Kochi, India

Yoji Kuze

Gifu City, Japan

Fuk Kei Fong

Hong Kong

Sebastian Mrad

Montreal, Canada

Krzysztof Badura

Lodz, Poland

Rafael Garcia-Borbolla

Sevilla, Spain

Jesus Alberto Martinez Alvarez

Centro, Mexico

Juan Felipe Ortega Restrepo

London, United Kingdom

Fatih Buyukbas

1-year SELUTION DeNovo results: what they mean for daily practice

29 Oct 2025

The SELUTION DeNovo trial, presented by Christian Spaulding at TCT 2025, delivers the first head-to-head comparison between a sirolimus DCB strategy and contemporary DES in PCI.

In this review, Salvatore Brugaletta breaks down the 1-year results and what these findings truly mean for everyday lesion-by-lesion decision-making.

Author

Guillaume BONNET

Author

Christian Spaulding

Author

Salvatore Brugaletta

Caglayan Demirel

Wien, Austria

EuroPCR 2026: Submit your Late-Breaking Trials

Call for Late-Breaking Trials is still open! Share your best work today and take the stage in Paris in May! Help shape the future of the field, don’t miss this opportunity.